Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free AMBA Stock Alerts

Ambarella (AMBA) Financials

Ambarella logo
$81.44 -0.66 (-0.80%)
As of 11:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Ambarella

Annual Income Statements for Ambarella

This table shows Ambarella's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 77 58 19 -30 -45 -60 -26 -65 -169 -117 -76
Consolidated Net Income / (Loss)		 77 58 19 -30 -45 -60 -26 -65 -169 -117 -76
Net Income / (Loss) Continuing Operations		 77 58 19 -30 -45 -60 -26 -65 -169 -117 -76
Total Pre-Tax Income 		85 61 26 -35 -42 -57 -29 -71 -149 -118 -74
Total Operating Income		 85 60 24 -40 -50 -61 -30 -74 -155 -127 -83
Total Gross Profit		 205 205 188 138 133 136 208 209 137 172 231
Total Revenue		 316 310 295 228 229 223 332 338 226 285 391
Operating Revenue		 316 310 295 228 229 223 332 338 226 285 391
Total Cost of Revenue		 111 105 108 90 96 87 124 129 90 113 159
Operating Cost of Revenue		 111 105 108 90 96 87 124 129 90 113 159
Total Operating Expenses		 121 145 163 179 182 197 238 283 291 299 314
Selling, General & Admin Expense		 38 43 48 50 53 56 70 78 76 73 75
Research & Development Expense		 83 101 116 128 130 141 167 205 215 226 239
Total Other Income / (Expense), net		 0.53 0.52 1.30 5.87 8.02 3.86 1.00 3.32 6.03 8.87 8.83
Other Income / (Expense), net		 0.53 0.52 1.30 5.87 8.02 3.86 1.00 3.32 6.03 8.87 8.83
Income Tax Expense		 8.70 3.07 6.88 -4.11 3.16 2.48 -2.23 -5.55 21 -0.60 2.17
Basic Earnings per Share		 $2.42 $1.77 $0.57 ($0.93) ($1.35) ($1.72) ($0.72) ($1.70) ($4.25) ($2.84) ($1.78)
Weighted Average Basic Shares Outstanding		 31.63M 32.67M 33.22M 32.71M 33.08M 34.68M 36.58M 38.36M 39.88M 41.30M 42.70M
Diluted Earnings per Share		 $2.27 $1.68 $0.55 ($0.93) ($1.35) ($1.72) ($0.72) ($1.70) ($4.25) ($2.84) ($1.78)
Weighted Average Diluted Shares Outstanding		 33.76M 34.33M 34.58M 32.71M 33.08M 34.68M 36.58M 38.36M 39.88M 41.30M 42.70M
Weighted Average Basic & Diluted Shares Outstanding		 31.60M 32.70M 33.10M 28.50M 34.21M 36.25M 38.07M 39.58M 40.96M 42.44M 43.79M

Quarterly Income Statements for Ambarella

This table shows Ambarella's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2025 7/31/2024 10/31/2024 1/31/2025 7/31/2025 10/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -8.24 -36 -31 -42 -61 -24 -35 -24 -20 -20 -15
Consolidated Net Income / (Loss)		 -11 -36 -31 -42 -61 -24 -35 -24 -20 -20 -15
Net Income / (Loss) Continuing Operations		 -8.24 -36 -31 -42 -61 -24 -35 -24 -20 -20 -15
Total Pre-Tax Income 		-22 -34 -35 -40 -40 -24 -34 -23 -23 -20 -14
Total Operating Income		 -23 -36 -35 -42 -42 -26 -36 -26 -25 -22 -16
Total Gross Profit		 50 38 38 30 31 52 39 50 50 56 65
Total Revenue		 83 62 62 51 52 86 64 83 84 96 108
Operating Revenue		 83 62 62 51 52 86 64 83 84 96 108
Total Cost of Revenue		 34 25 24 21 21 34 25 33 34 39 44
Operating Cost of Revenue		 34 25 24 21 21 34 25 33 34 39 44
Total Operating Expenses		 73 73 74 72 73 77 75 76 76 78 81
Selling, General & Admin Expense		 20 19 19 18 21 19 18 17 19 18 19
Research & Development Expense		 53 54 55 54 52 59 57 58 57 60 61
Total Other Income / (Expense), net		 4.69 1.29 0.74 1.90 2.11 2.18 2.15 2.09 2.36 2.25 2.07
Other Income / (Expense), net		 4.69 1.29 0.74 1.90 2.11 2.18 2.15 2.09 2.36 2.25 2.07
Income Tax Expense		 -11 1.65 -3.40 1.65 21 0.65 0.75 0.65 -2.76 0.25 0.93
Basic Earnings per Share		 ($0.28) ($0.91) ($0.79) ($1.04) ($1.51) ($0.58) ($0.85) ($0.58) ($0.48) ($0.47) ($0.35)
Weighted Average Basic Shares Outstanding		 38.36M 39.34M 39.74M 40.05M 39.88M 42.22M 41.13M 41.48M 41.30M 42.55M 42.87M
Diluted Earnings per Share		 ($0.28) ($0.91) ($0.79) ($1.04) ($1.51) ($0.58) ($0.85) ($0.58) ($0.48) ($0.47) ($0.35)
Weighted Average Diluted Shares Outstanding		 38.36M 39.34M 39.74M 40.05M 39.88M 42.22M 41.13M 41.48M 41.30M 42.55M 42.87M
Weighted Average Basic & Diluted Shares Outstanding		 39.58M 39.60M 39.88M 40.25M 40.96M 42.41M 41.27M 41.70M 42.44M 42.69M 43.05M

Annual Cash Flow Statements for Ambarella

This table details how cash moves in and out of Ambarella's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents		 98 55 24 -153 37 9.87 -70 -58 31 -0.29 47
Net Cash From Operating Activities		 124 113 85 24 39 31 39 44 19 34 74
Net Cash From Continuing Operating Activities		 124 113 85 24 39 31 39 44 19 34 74
Net Income / (Loss) Continuing Operations		 77 58 19 -30 -45 -60 -26 -65 -169 -117 -76
Consolidated Net Income / (Loss)		 77 58 19 -30 -45 -60 -26 -65 -169 -117 -76
Depreciation Expense		 1.59 1.54 4.77 7.22 12 12 14 20 25 26 26
Amortization Expense		 0.54 0.30 0.17 -0.67 -0.97 0.72 1.03 -0.68 -1.15 -0.58 -0.17
Non-Cash Adjustments To Reconcile Net Income		 31 49 57 61 67 70 87 110 112 108 98
Changes in Operating Assets and Liabilities, net		 14 4.76 4.58 -13 6.74 7.70 -37 -20 52 17 26
Net Cash From Investing Activities		 -35 -46 -9.60 -79 -8.58 -31 -120 -107 7.84 -41 -30
Net Cash From Continuing Investing Activities		 -35 -46 -9.60 -79 -8.58 -31 -120 -107 7.84 -41 -30
Purchase of Property, Plant & Equipment		 -2.09 -2.70 -3.69 -2.94 -1.82 -4.94 -9.68 -15 -12 -10 -16
Purchase of Investments		 -53 -116 -75 -208 -226 -220 -119 -97 -34 -71 -63
Sale and/or Maturity of Investments		 50 73 69 132 219 193 316 4.44 54 41 48
Net Cash From Financing Activities		 9.00 -13 -52 -98 6.52 10 11 5.70 4.51 6.40 3.81
Net Cash From Continuing Financing Activities		 9.00 -13 -52 -98 6.52 10 11 5.70 4.51 6.40 3.81
Repurchase of Common Equity		 0.00 -20 -55 -100 0.00 -1.00 - - 0.00 0.00 -1.00
Other Financing Activities, net		 9.00 7.42 2.79 1.95 6.52 11 11 5.70 4.51 6.40 4.81
Cash Income Taxes Paid		 1.62 2.07 0.85 1.41 1.81 1.53 1.87 1.44 7.11 1.42 2.27

Quarterly Cash Flow Statements for Ambarella

This table details how cash moves in and out of Ambarella's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q3 2026 Q4 2026
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2025 7/31/2024 10/31/2024 1/31/2025 10/31/2025 1/31/2026
Net Change in Cash & Equivalents		 0.71 14 -5.23 21 1.13 -2.90 22 -27 18 31 17
Net Cash From Operating Activities		 5.09 22 -6.84 7.87 -4.03 15 17 6.62 25 34 19
Net Cash From Continuing Operating Activities		 5.09 22 -6.84 7.87 -4.03 15 17 6.62 25 34 19
Net Income / (Loss) Continuing Operations		 -11 -36 -31 -42 -61 -24 -35 -24 -20 -15 -16
Consolidated Net Income / (Loss)		 -11 -36 -31 -42 -61 -24 -35 -24 -20 -15 -16
Depreciation Expense		 5.51 5.82 6.12 6.46 6.41 6.75 6.40 6.48 6.83 6.51 5.69
Amortization Expense		 -0.40 -0.37 -0.34 -0.25 -0.20 -0.07 -0.17 -0.12 -0.09 -0.03 -0.01
Non-Cash Adjustments To Reconcile Net Income		 28 27 29 24 32 26 28 27 28 26 21
Changes in Operating Assets and Liabilities, net		 -17 25 -11 20 18 6.56 18 -2.27 11 17 8.38
Net Cash From Investing Activities		 -8.14 -8.21 0.24 13 2.79 -16 3.62 -36 -10 -5.00 -4.39
Net Cash From Continuing Investing Activities		 -8.14 -8.21 0.24 13 2.79 -16 3.62 -36 -10 -5.00 -4.39
Purchase of Property, Plant & Equipment		 -2.03 -2.30 -5.40 -2.35 -1.93 -4.57 -2.56 -2.50 -4.19 -2.90 -3.92
Purchase of Investments		 -9.80 -20 -14 -0.26 0.26 -21 -1.61 -49 -13 -19 -9.40
Sale and/or Maturity of Investments		 3.69 14 20 16 4.47 9.46 7.79 16 7.05 16 8.93
Net Cash From Financing Activities		 3.75 0.39 1.37 0.38 2.37 -1.55 1.76 2.40 2.54 2.01 2.46
Net Cash From Continuing Financing Activities		 3.75 0.39 1.37 0.38 2.37 -1.55 1.76 2.40 2.54 2.01 2.46
Other Financing Activities, net		 3.75 0.39 1.37 0.38 2.37 -0.55 1.76 2.40 2.54 2.01 2.46
Cash Income Taxes Paid		 0.10 1.25 1.72 2.52 1.61 0.29 0.67 0.48 -0.82 0.49 0.95

Annual Balance Sheets for Ambarella

This table presents Ambarella's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets		 411 512 547 467 527 573 658 710 658 689 799
Total Current Assets		 370 469 493 410 451 497 267 305 280 321 410
Cash & Equivalents		 268 323 347 194 231 241 171 114 145 145 191
Restricted Cash		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.44
Short-Term Investments		 40 83 88 165 173 199 0.00 93 75 106 122
Accounts Receivable		 39 39 31 26 18 25 44 52 25 30 39
Inventories, net		 18 20 23 18 23 26 45 40 29 34 52
Prepaid Expenses		 4.17 4.39 4.01 6.21 4.98 5.53 6.17 5.29 6.23 6.08 5.84
Plant, Property, & Equipment, net		 3.45 4.99 6.45 6.73 16 15 10 20 10 14 12
Total Noncurrent Assets		 38 39 47 51 61 61 381 385 367 354 377
Goodwill		 27 27 27 27 27 27 304 304 304 304 304
Intangible Assets		 4.18 4.15 14 11 18 19 46 58 55 47 58
Other Noncurrent Operating Assets		 2.12 2.22 2.26 2.41 5.71 4.57 15 4.01 8.30 3.24 15
Total Liabilities & Shareholders' Equity		 411 512 547 467 527 573 658 710 658 689 799
Total Liabilities		 61 58 64 47 79 98 110 104 98 128 204
Total Current Liabilities		 49 54 53 39 53 74 89 83 83 121 178
Accounts Payable		 14 20 20 13 15 21 31 18 29 22 54
Accrued Expenses		 24 26 32 25 35 48 52 57 49 81 98
Current Deferred Revenue		 10 7.43 0.31 0.53 0.70 0.84 1.41 1.31 0.89 14 22
Current Deferred & Payable Income Tax Liabilities		 0.79 0.57 0.94 0.99 0.69 0.96 1.25 4.11 1.54 1.38 1.53
Other Current Liabilities		 - - - 0.00 2.18 2.91 3.39 3.54 3.44 2.83 2.03
Total Noncurrent Liabilities		 12 3.24 11 8.34 26 24 21 21 15 6.56 26
Capital Lease Obligations		 - - - 0.00 7.98 7.53 - 5.10 1.90 2.44 11
Other Noncurrent Operating Liabilities		 12 3.24 11 8.34 18 17 21 16 13 4.13 14
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 349 455 482 419 448 475 547 606 560 561 595
Total Preferred & Common Equity		 349 455 482 419 448 475 547 606 560 561 595
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 349 455 482 419 448 475 547 606 560 561 595
Common Stock		 176 212 221 189 261 347 447 572 695 814 922
Retained Earnings		 173 242 261 231 186 126 100 34 -135 -252 -328
Accumulated Other Comprehensive Income / (Loss)		 -0.01 -0.07 -0.28 0.10 0.77 1.22 0.00 -0.49 -0.18 -0.23 0.57

Quarterly Balance Sheets for Ambarella

This table presents Ambarella's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q2 2026 Q3 2026
Period end date 4/30/2022 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2025 7/31/2024 10/31/2024 7/31/2025 10/31/2025
Total Assets		 669 674 687 705 696 685 702 650 671 706 752
Total Current Assets		 278 283 298 305 287 280 336 280 304 344 384
Cash & Equivalents		 201 195 113 128 123 144 141 154 127 143 174
Restricted Cash		 0.01 0.01 0.01 0.01 0.01 0.01 0.44 0.01 0.01 0.44 0.44
Short-Term Investments		 - 2.97 86 100 94 79 118 66 99 118 121
Accounts Receivable		 28 38 49 30 30 23 30 23 34 43 42
Inventories, net		 42 40 45 41 35 31 39 31 37 34 39
Prepaid Expenses		 8.15 7.14 5.34 6.08 5.20 3.73 6.20 6.05 6.52 5.54 6.54
Plant, Property, & Equipment, net		 20 21 20 11 11 11 10 9.04 9.68 10 11
Total Noncurrent Assets		 370 371 369 389 398 394 356 362 357 352 357
Goodwill		 304 304 304 304 304 304 304 304 304 3.50 304
Intangible Assets		 48 50 48 56 63 59 45 48 45 42 38
Other Noncurrent Operating Assets		 3.83 3.50 3.43 11 9.42 8.51 7.60 9.42 8.91 307 16
Total Liabilities & Shareholders' Equity		 669 674 687 705 696 685 702 650 671 706 752
Total Liabilities		 94 96 99 99 94 93 129 103 116 130 162
Total Current Liabilities		 75 78 81 80 75 76 125 91 107 126 144
Accounts Payable		 30 22 29 26 12 9.30 35 19 25 27 35
Accrued Expenses		 39 48 44 46 54 58 73 62 73 76 88
Current Deferred Revenue		 0.96 0.46 1.04 1.33 2.71 2.60 12 5.15 4.58 19 18
Current Deferred & Payable Income Tax Liabilities		 1.48 3.11 3.78 3.62 2.46 2.39 1.63 0.81 0.84 1.71 1.89
Other Current Liabilities		 3.29 3.51 3.43 3.57 3.55 3.55 2.34 3.65 3.25 1.77 1.73
Total Noncurrent Liabilities		 19 19 18 18 19 17 4.35 11 9.62 3.97 17
Capital Lease Obligations		 7.44 7.02 5.90 - - - 2.06 3.10 2.72 1.67 12
Other Noncurrent Operating Liabilities		 12 12 12 18 19 17 2.30 8.23 6.91 2.30 5.41
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 574 578 588 606 602 592 573 548 554 577 590
Total Preferred & Common Equity		 574 578 588 606 602 592 573 548 554 577 590
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 574 578 588 606 602 592 573 548 554 577 590
Common Stock		 485 513 544 608 636 667 849 755 786 873 901
Retained Earnings		 89 65 46 -1.42 -33 -74 -276 -208 -232 -296 -311
Accumulated Other Comprehensive Income / (Loss)		 - -0.00 -1.04 -0.38 -0.93 -1.22 0.33 -0.17 -0.30 0.06 0.53

Annual Metrics And Ratios for Ambarella

This table displays calculated financial ratios and metrics derived from Ambarella's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 43,050,486.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 43,050,486.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -1.76
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 76 57 18 -28 -35 -43 -21 -52 -108 -89 -58
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -8.50% -19.26% -15.72% -9.53%
Earnings before Interest and Taxes (EBIT)		 85 61 26 -35 -42 -57 -29 -71 -149 -118 -74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 87 63 31 -28 -31 -45 -14 -52 -125 -92 -48
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 64 50 20 -41 -25 -33 -355 -80 -46 -60 -37
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 42 49 48 61 51 42 376 404 342 314 293
Increase / (Decrease) in Invested Capital		 12 7.68 -1.65 13 -9.28 -9.51 334 28 -62 -28 -20
Book Value per Share		 $10.90 $13.73 $14.48 $13.09 $13.36 $13.50 $14.79 $15.64 $13.91 $13.46 $13.82
Tangible Book Value per Share		 $9.94 $12.80 $13.25 $11.92 $12.03 $12.22 $5.33 $6.29 $5.00 $5.05 $5.42
Total Capital		 349 455 482 419 456 483 547 611 562 564 606
Total Debt		 0.00 0.00 0.00 0.00 7.98 7.53 0.00 5.10 1.90 2.44 11
Total Long-Term Debt		 0.00 0.00 0.00 0.00 7.98 7.53 0.00 5.10 1.90 2.44 11
Net Debt		 -308 -405 -435 -359 -397 -433 -171 -202 -218 -248 -302
Capital Expenditures (CapEx)		 2.09 2.70 3.69 2.94 1.82 4.94 9.68 15 12 10 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 13 8.74 5.45 12 -7.02 -17 6.41 14 -23 -51 -81
Debt-free Net Working Capital (DFNWC)		 321 414 440 371 398 423 177 221 197 200 232
Net Working Capital (NWC)		 321 414 440 371 398 423 177 221 197 200 232
Net Nonoperating Expense (NNE)		 -0.48 -0.49 -0.95 2.15 10 17 5.66 13 61 29 18
Net Nonoperating Obligations (NNO)		 -308 -405 -435 -359 -397 -433 -171 -202 -218 -248 -302
Total Depreciation and Amortization (D&A)		 2.13 1.83 4.94 6.55 11 13 15 19 24 25 25
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.42 $1.77 $0.57 ($0.93) ($1.35) ($1.72) ($0.72) ($1.70) ($4.25) ($2.84) ($1.78)
Adjusted Weighted Average Basic Shares Outstanding		 31.63M 32.67M 33.22M 32.71M 33.08M 34.68M 36.58M 38.36M 39.88M 41.30M 42.70M
Adjusted Diluted Earnings per Share		 $2.27 $1.68 $0.55 ($0.93) ($1.35) ($1.72) ($0.72) ($1.70) ($4.25) ($2.84) ($1.78)
Adjusted Weighted Average Diluted Shares Outstanding		 33.76M 34.33M 34.58M 32.71M 33.08M 34.68M 36.58M 38.36M 39.88M 41.30M 42.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.33M 33.52M 33.64M 32.72M 34.21M 36.25M 38.07M 39.58M 40.96M 42.44M 43.79M
Normalized Net Operating Profit after Tax (NOPAT)		 76 57 18 -28 -35 -43 -21 -52 -108 -89 -58
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Ambarella

This table displays calculated financial ratios and metrics derived from Ambarella's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 7/31/2025 10/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.66% -31.19% -23.20% -39.11% -38.05% -12.34% 2.58% 63.36% 62.77% 49.88% 31.21%
EBITDA Growth		 -77.55% -396.23% -85.63% -102.57% -144.76% -7.72% 3.17% 49.61% 51.31% 30.57% 54.92%
EBIT Growth		 -49.37% -229.01% -71.18% -85.80% -111.25% -8.52% 1.33% 41.55% 41.95% 42.18% 39.48%
NOPAT Growth		 -90.01% -238.56% -75.05% -108.47% -77.96% -10.98% -2.68% 39.21% 39.22% 39.40% 36.31%
Net Income Growth		 -20.80% -231.75% -31.92% -110.56% -445.76% -5.65% -11.83% 42.29% 66.61% 42.69% 37.24%
EPS Growth		 -16.67% -213.79% -27.42% -103.92% -439.29% -2.20% -7.59% 44.23% 68.21% 44.71% 39.66%
Operating Cash Flow Growth		 -75.26% -34.37% -1,127.65% 31.15% -179.21% -167.88% 344.78% -15.89% 730.70% 0.00% 418.42%
Free Cash Flow Firm Growth		 87.00% 93.05% 93.13% 98.92% 174.62% 90.55% 226.72% 691.84% -68.42% -103.77% -39.26%
Invested Capital Growth		 7.50% -0.61% -0.36% -6.53% -15.45% -6.73% -14.25% -10.55% -8.27% -4.32% -7.32%
Revenue Q/Q Growth		 0.27% -25.42% -0.03% -18.55% 2.02% 5.54% 16.98% 29.70% 1.65% 0.00% 13.55%
EBITDA Q/Q Growth		 18.37% -111.10% -0.07% -17.46% 1.36% 7.09% 10.05% 38.87% 4.70% 0.00% 61.05%
EBIT Q/Q Growth		 13.05% -82.71% -1.01% -15.79% 1.14% 6.14% 8.16% 31.41% 1.82% 0.00% 28.20%
NOPAT Q/Q Growth		 -16.44% -51.63% 0.57% -18.75% 0.60% 5.44% 8.01% 29.70% 0.62% 0.00% 26.11%
Net Income Q/Q Growth		 43.94% -223.30% 13.10% -33.69% -45.31% 37.41% 8.02% 31.01% 15.94% 0.00% 24.45%
EPS Q/Q Growth		 45.10% -225.00% 13.19% -31.65% -45.19% 38.41% 8.60% 31.76% 17.24% 0.00% 25.53%
Operating Cash Flow Q/Q Growth		 -15.17% 332.71% -131.05% 215.08% -151.24% -270.81% 211.95% -60.46% 284.20% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 86.44% 49.47% -3.49% 84.71% 1,033.16% -106.40% 1,487.33% -28.59% -50.21% 0.00% 1,249.50%
Invested Capital Q/Q Growth		 2.29% -6.31% 1.85% -4.24% -7.47% 3.36% -6.36% -0.11% -5.12% 0.00% -3.25%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 59.58% 60.38% 61.91% 59.26% 59.77% 60.87% 60.80% 60.55% 59.97% 58.87% 59.55%
EBITDA Margin		 -16.37% -46.35% -46.40% -66.91% -64.70% -56.95% -43.79% -20.64% -19.35% -20.67% -7.09%
Operating Margin		 -28.13% -57.19% -56.89% -82.94% -80.82% -72.41% -56.94% -30.86% -30.18% -23.02% -14.98%
EBIT Margin		 -22.50% -55.13% -55.70% -79.19% -76.73% -68.24% -53.58% -28.33% -27.37% -20.67% -13.07%
Profit (Net Income) Margin		 -13.33% -57.77% -50.22% -82.44% -117.42% -69.63% -54.75% -29.12% -24.08% -20.93% -13.93%
Tax Burden Percent		 51.38% 104.81% 90.16% 104.11% 153.02% 102.04% 102.19% 102.78% 88.00% 101.28% 106.58%
Interest Burden Percent		 115.29% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -17.04% -32.61% -29.95% -39.20% -34.34% -30.30% -24.52% -15.59% -18.36% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -19.88% -27.36% -26.78% -33.27% -19.38% -25.49% -20.14% -12.80% -17.29% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 6.43% 9.75% 9.24% 11.71% 6.98% 9.43% 7.59% 4.98% 7.19% 0.00% 0.00%
Return on Equity (ROE)		 -10.61% -22.86% -20.71% -27.49% -27.36% -20.87% -16.93% -10.60% -11.18% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 -20.55% -17.68% -20.36% -18.20% -12.25% -23.34% -15.80% -17.46% -18.42% 0.00% 0.00%
Operating Return on Assets (OROA)		 -11.11% -24.84% -23.63% -29.80% -25.41% -22.23% -17.54% -10.56% -11.58% 0.00% 0.00%
Return on Assets (ROA)		 -6.58% -26.03% -21.30% -31.02% -38.88% -22.68% -17.92% -10.85% -10.19% 0.00% 0.00%
Return on Common Equity (ROCE)		 -10.61% -22.86% -20.71% -27.49% -27.36% -20.87% -16.93% -10.60% -11.18% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -14.92% -16.27% -20.26% 0.00% -30.87% -31.99% -28.41% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -16 -25 -25 -29 -29 -28 -25 -18 -18 -15 -11
NOPAT Margin		 -19.69% -40.04% -39.82% -58.06% -56.57% -50.69% -39.86% -21.60% -21.12% -16.12% -10.49%
Net Nonoperating Expense Percent (NNEP)		 2.84% -5.24% -3.17% -5.94% -14.96% -4.81% -4.38% -2.79% -1.07% -1.93% -1.47%
Return On Investment Capital (ROIC_SIMPLE)		 -2.68% - - - -5.20% - - - -3.15% -2.66% -1.89%
Cost of Revenue to Revenue		 40.42% 39.62% 38.09% 40.74% 40.23% 39.13% 39.21% 39.45% 40.03% 41.13% 40.45%
SG&A Expenses to Revenue		 24.04% 29.96% 30.40% 36.06% 39.86% 33.90% 28.67% 20.77% 22.51% 19.35% 17.87%
R&D to Revenue		 63.67% 87.61% 88.40% 106.14% 100.73% 99.38% 89.07% 70.64% 67.63% 62.54% 56.66%
Operating Expenses to Revenue		 87.72% 117.57% 118.80% 142.20% 140.59% 133.29% 117.74% 91.42% 90.14% 81.90% 74.53%
Earnings before Interest and Taxes (EBIT)		 -19 -34 -35 -40 -40 -37 -34 -23 -23 -20 -14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -14 -29 -29 -34 -33 -31 -28 -17 -16 -20 -7.69
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.74 4.05 5.48 3.03 3.78 3.39 3.94 4.18 5.70 4.86 6.17
Price to Tangible Book Value (P/TBV)		 14.27 9.93 14.02 7.82 10.52 9.38 11.03 11.27 15.20 5.28 14.64
Price to Revenue (P/Rev)		 10.31 7.93 11.37 6.95 9.34 8.61 9.79 9.19 11.23 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 8.11 5.88 8.00 4.25 5.55 4.76 5.87 6.34 9.41 8.03 10.95
Enterprise Value to Revenue (EV/Rev)		 9.72 7.19 10.62 6.09 8.38 7.68 8.81 8.30 10.36 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 74.39 68.37 117.48 55.84 99.74 0.00 345.08 479.06 87.23 48.57 41.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.02
Long-Term Debt to Equity		 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.02
Financial Leverage		 -0.32 -0.36 -0.35 -0.35 -0.36 -0.37 -0.38 -0.39 -0.42 -0.42 -0.44
Leverage Ratio		 1.19 1.16 1.16 1.16 1.17 1.16 1.17 1.18 1.20 1.21 1.24
Compound Leverage Factor		 1.37 1.16 1.16 1.16 1.17 1.16 1.17 1.18 1.20 1.21 1.24
Debt to Total Capital		 0.83% 0.00% 0.00% 0.00% 0.34% 0.22% 0.56% 0.49% 0.43% 0.29% 1.98%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.83% 0.00% 0.00% 0.00% 0.34% 0.22% 0.56% 0.49% 0.43% 0.29% 1.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.17% 100.00% 100.00% 100.00% 99.66% 99.78% 99.44% 99.51% 99.57% 99.71% 98.02%
Debt to EBITDA		 -0.10 0.00 0.00 0.00 -0.02 -0.01 -0.02 -0.02 -0.03 0.00 0.00
Net Debt to EBITDA		 3.90 0.00 0.00 0.00 1.75 1.59 1.72 2.05 2.69 0.00 0.00
Long-Term Debt to EBITDA		 -0.10 0.00 0.00 0.00 -0.02 -0.01 -0.02 -0.02 -0.03 0.00 0.00
Debt to NOPAT		 -0.10 0.00 0.00 0.00 -0.02 -0.01 -0.03 -0.03 -0.03 0.00 0.00
Net Debt to NOPAT		 3.88 0.00 0.00 0.00 2.02 1.82 1.94 2.24 2.80 0.00 0.00
Long-Term Debt to NOPAT		 -0.10 0.00 0.00 0.00 -0.02 -0.01 -0.03 -0.03 -0.03 0.00 0.00
Altman Z-Score		 20.90 15.59 21.66 11.98 13.20 13.71 12.66 12.07 15.19 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.65 3.80 3.84 3.69 3.38 3.69 3.06 2.84 2.65 2.73 2.66
Quick Ratio		 3.10 3.21 3.30 3.24 2.95 3.21 2.66 2.44 2.31 2.41 2.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -45 -23 -23 -3.57 33 -2.13 30 21 11 -1.12 13
Operating Cash Flow to CapEx		 250.99% 958.44% -126.72% 334.42% -208.91% -1,320.76% 652.81% 264.76% 607.65% 0.00% 1,182.43%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.45 0.42 0.38 0.33 0.33 0.33 0.37 0.42 0.00 0.00
Accounts Receivable Turnover		 7.01 10.70 8.57 7.22 5.89 7.53 8.27 8.87 10.41 0.00 0.00
Inventory Turnover		 3.00 2.89 3.03 2.69 2.58 2.48 2.68 2.96 3.55 0.00 0.00
Fixed Asset Turnover		 22.29 19.52 18.19 16.73 14.81 20.80 21.73 24.51 29.18 0.00 0.00
Accounts Payable Turnover		 5.25 4.32 6.67 5.34 3.87 4.10 5.59 5.77 4.48 0.00 0.00
Days Sales Outstanding (DSO)		 52.05 34.11 42.60 50.56 62.00 48.48 44.15 41.16 35.05 0.00 0.00
Days Inventory Outstanding (DIO)		 121.56 126.33 120.52 135.54 141.53 146.99 136.20 123.37 102.93 0.00 0.00
Days Payable Outstanding (DPO)		 69.52 84.56 54.76 68.37 94.34 88.97 65.33 63.22 81.54 0.00 0.00
Cash Conversion Cycle (CCC)		 104.09 75.88 108.37 117.73 109.18 106.50 115.02 101.31 56.45 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 404 379 386 369 342 353 331 330 314 317 306
Invested Capital Turnover		 0.87 0.81 0.75 0.68 0.61 0.60 0.62 0.72 0.87 0.00 0.00
Increase / (Decrease) in Invested Capital		 28 -2.34 -1.41 -26 -62 -25 -55 -39 -28 -14 -24
Enterprise Value (EV)		 3,280 2,226 3,087 1,572 1,897 1,681 1,941 2,095 2,952 2,543 3,355
Market Capitalization		 3,482 2,453 3,304 1,794 2,115 1,883 2,157 2,319 3,199 2,803 3,638
Book Value per Share		 $15.64 $15.32 $15.21 $14.84 $13.91 $13.56 $13.36 $13.43 $13.46 $13.59 $13.82
Tangible Book Value per Share		 $6.29 $6.24 $5.95 $5.75 $5.00 $4.90 $4.77 $4.98 $5.05 $12.52 $5.82
Total Capital		 611 606 602 592 562 557 551 557 564 578 602
Total Debt		 5.10 0.00 0.00 0.00 1.90 1.24 3.10 2.72 2.44 1.67 12
Total Long-Term Debt		 5.10 0.00 0.00 0.00 1.90 1.24 3.10 2.72 2.44 1.67 12
Net Debt		 -202 -227 -217 -222 -218 -202 -217 -224 -248 -260 -284
Capital Expenditures (CapEx)		 2.03 2.30 5.40 2.35 1.93 1.13 2.56 2.50 4.19 0.00 2.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 14 -3.02 -4.56 -18 -23 -8.69 -32 -30 -51 -44 -57
Debt-free Net Working Capital (DFNWC)		 221 224 212 204 197 195 188 197 200 218 239
Net Working Capital (NWC)		 221 224 212 204 197 195 188 197 200 218 239
Net Nonoperating Expense (NNE)		 -5.30 11 6.46 12 31 10 9.49 6.21 2.49 4.60 3.73
Net Nonoperating Obligations (NNO)		 -202 -227 -217 -222 -218 -202 -217 -224 -248 -260 -284
Total Depreciation and Amortization (D&A)		 5.11 5.46 5.78 6.21 6.21 6.15 6.24 6.36 6.74 0.00 6.48
Debt-free, Cash-free Net Working Capital to Revenue		 4.24% -0.98% -1.57% -7.11% -10.05% -3.97% -14.33% -11.80% -17.80% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 65.51% 72.51% 72.92% 79.01% 87.06% 88.97% 85.40% 77.93% 70.05% 0.00% 0.00%
Net Working Capital to Revenue		 65.51% 72.51% 72.92% 79.01% 87.06% 88.97% 85.40% 77.93% 70.05% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.28) ($0.91) ($0.79) ($1.04) ($1.51) ($0.93) ($0.85) ($0.58) ($0.48) ($0.47) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding		 38.36M 39.34M 39.74M 40.05M 39.88M 40.77M 41.13M 41.48M 41.30M 42.55M 42.87M
Adjusted Diluted Earnings per Share		 ($0.28) ($0.91) ($0.79) ($1.04) ($1.51) ($0.93) ($0.85) ($0.58) ($0.48) ($0.47) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding		 38.36M 39.34M 39.74M 40.05M 39.88M 40.77M 41.13M 41.48M 41.30M 42.55M 42.87M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 39.58M 39.60M 39.88M 40.25M 40.96M 40.99M 41.27M 41.70M 42.44M 42.69M 43.05M
Normalized Net Operating Profit after Tax (NOPAT)		 -16 -25 -25 -29 -29 -28 -25 -18 -18 -15 -11
Normalized NOPAT Margin		 -19.69% -40.04% -39.82% -58.06% -56.57% -50.69% -39.86% -21.60% -21.12% -16.12% -10.49%
Pre Tax Income Margin		 -25.94% -55.13% -55.70% -79.19% -76.73% -68.24% -53.58% -28.33% -27.37% -20.67% -13.07%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor-focused synthesis of Ambarella (AMBA) quarterly results over the last four calendar years, focusing on cash flow, profitability, and balance-sheet trends. The focus is on what has changed over time and what might matter to a retail investor.

  • Positive operating cash flow across recent quarters: Net cash from continuing operating activities was strong in Q3 2026 ($34.31m) and remained positive in Q4 2026 ($18.90m) and Q2 2026 ($16.74m), with Q4 2025 also showing solid cash generation ($25.43m).
  • Revenue momentum into 2026: Operating revenue rose from about $95.51m in Q2 2026 to $108.45m in Q3 2026, indicating top-line strength and sequential growth.
  • Healthy gross margins in recent quarters: Gross profit in Q3 2026 was $64.59m on $108.45m revenue (roughly 60% gross margin), underscoring a solid gross margin profile despite a negative net income.
  • Strong liquidity with a growing cash balance: Cash and equivalents stood at about $174.06m in Q3 2026, up from about $142.74m in Q2 2026, signaling ample liquidity for near-term needs.
  • Non-cash adjustments boosting cash flow: Non-cash adjustments to reconcile net income were sizable (e.g., $25.55m in Q3 2026 and $21.26m in Q4 2026), helping translate earnings down into cash flow from operations.
  • Net income remains negative in recent quarters: The company has posted quarterly net losses (e.g., Q3 2026 net income continuing operations around −$15.1m; Q4 2026 around −$16.4m), so profitability trends remain a concern even with positive cash flow.
  • R&D expenditure remains elevated: Research & Development expense is a major line item (for example, around $61.5m in Q3 2026), contributing to ongoing losses but reflecting investment in product development.
  • Ongoing quarterly net losses: Recurrent negative net income streams (e.g., Q3 2026: −$15.1m; Q4 2026: −$16.4m) indicate cash generation is not yet translating into GAAP profitability.
  • Investing cash outflows persist: Net cash used in investing activities remains negative in recent quarters, reflecting acquisitions and capex that weigh on cash despite positive operating cash flow.
  • Rising liabilities over time: Total liabilities increased in 2026 to around $161.8m (versus about $129.9m in 2025), contributing to a higher leverage profile even as equity remains sizable.
05/14/26 09:58 AM ETAI Generated. May Contain Errors.

Ambarella Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ambarella's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Ambarella's net income appears to be on an upward trend, with a most recent value of -$75.87 million in 2026, falling from $76.51 million in 2016. The previous period was -$117.13 million in 2025. Find out what analysts predict for Ambarella in the coming months.

Ambarella's total operating income in 2026 was -$82.53 million, based on the following breakdown:
  • Total Gross Profit: $231.27 million
  • Total Operating Expenses: $313.79 million

Over the last 10 years, Ambarella's total revenue changed from $316.37 million in 2016 to $390.70 million in 2026, a change of 23.5%.

Ambarella's total liabilities were at $203.81 million at the end of 2026, a 59.8% increase from 2025, and a 233.2% increase since 2016.

In the past 10 years, Ambarella's cash and equivalents has ranged from $113.54 million in 2023 to $346.67 million in 2018, and is currently $191.02 million as of their latest financial filing in 2026.

Over the last 10 years, Ambarella's book value per share changed from 10.90 in 2016 to 13.82 in 2026, a change of 26.7%.


Related Companies

Financial statements for NASDAQ:AMBA last updated on 3/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
One coin wired into Elon's vision
The SpaceX IPO is going to be the biggest in human history. $1.75 trillion. $75 billion raised. And Wall St...
Crypto 101 Media | Sponsoredtc pixel
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel